Evidence map›Paper›PMID 30023654›Full record

ArticleACS omega2017

Development of

David M Charbonneau, Alexandra Aubé, Natalie M Rachel, Vanessa Guerrero, Kevin Delorme, Julien Breault-Turcot, Jean-François Masson, Joelle N Pelletier

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. A conserved SH3-like fold in diverse putative proteins tetramerizes into an oxidoreductase providing an antimicrobial resistance phenotype.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

David M CharbonneauDépartement de Chimie and Département de Biochimie, Université de Montréal, Montréal, Québec H3T 1J4, Canada.
Alexandra AubéDépartement de Chimie and Département de Biochimie, Université de Montréal, Montréal, Québec H3T 1J4, Canada.
Natalie M RachelDépartement de Chimie and Département de Biochimie, Université de Montréal, Montréal, Québec H3T 1J4, Canada.
Vanessa GuerreroDépartement de Chimie and Département de Biochimie, Université de Montréal, Montréal, Québec H3T 1J4, Canada.
Kevin DelormeDépartement de Chimie and Département de Biochimie, Université de Montréal, Montréal, Québec H3T 1J4, Canada.
Julien Breault-TurcotDépartement de Chimie and Département de Biochimie, Université de Montréal, Montréal, Québec H3T 1J4, Canada.
Jean-François MassonDépartement de Chimie and Département de Biochimie, Université de Montréal, Montréal, Québec H3T 1J4, Canada.
Joelle N PelletierDépartement de Chimie and Département de Biochimie, Université de Montréal, Montréal, Québec H3T 1J4, Canada.
Centre in Green Chemistry and Catalysis · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The clinical success of

Identifiers

PMID30023654
PMCPMC6044767
OpenAlexW2614375104

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.